BRIEF published on 04/25/2025 at 14:05, 1 year 5 months ago Bausch Health Unveils Advanced Skin Resurfacing Technology at ASLMS 2025 Bausch Health Aesthetic Medicine Fraxel FTX™ Skin Resurfacing ASLMS 2025
PRESS RELEASE published on 04/25/2025 at 14:00, 1 year 5 months ago Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) Bausch Health unveiled Fraxel FTX™, the next-gen skin resurfacing tech, at ASLMS 2025, Orlando. Dual-wavelength laser treats skin concerns with visible results & minimal downtime Bausch Health Laser Technology Skin Resurfacing ASLMS 2025 Fraxel FTX
BRIEF published on 04/22/2025 at 13:30, 1 year 5 months ago Bausch Health Files Supplement to Proxy Statement Amid Icahn's Equity Swaps Proxy Statement Bausch Health Shareholder Rights Equity Swaps Carl Icahn
PRESS RELEASE published on 04/22/2025 at 13:25, 1 year 5 months ago Bausch Health Announces Filing of Supplement to Proxy Statement Bausch Health updates Proxy Statement to disclose 24.6% common shares held by Carl Icahn. Company adopts shareholder rights plan agreement to prevent 'creeping' take-over bids Proxy Statement Bausch Health Update Shareholder Rights Plan Carl Icahn
BRIEF published on 04/17/2025 at 21:45, 1 year 5 months ago Bausch Health Prevails in U.S. District Court Case Bausch Health Norwich Pharmaceuticals XIFAXAN® FDA Ruling Teva Exclusivity
PRESS RELEASE published on 04/17/2025 at 21:40, 1 year 5 months ago U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich Bausch Health and Salix Pharmaceuticals win U.S. District Court case against FDA regarding XIFAXAN, preserving patient access. Company to discuss financial results on April 30 FDA Financial Results Salix Pharmaceuticals XIFAXAN Bausch Health
BRIEF published on 04/14/2025 at 22:35, 1 year 6 months ago Bausch Health Adopts Shareholder Rights Plan Bausch Health TSX Approval Shareholder Rights Plan Take-over Protection Ratification Requirement
PRESS RELEASE published on 04/14/2025 at 22:30, 1 year 6 months ago Bausch Health Announces Adoption of Shareholder Rights Plan Bausch Health implements shareholder rights plan to safeguard fairness in take-over bids. Terms outlined for shareholder ratification within 6 months Bausch Health SRP Shareholder Rights Plan Take-over Bids Shareholder Ratification
BRIEF published on 04/10/2025 at 22:20, 1 year 6 months ago Bausch Health Launches 2025 ASPIRE HIGHER Scholarship Program Bausch Health Higher Education Scholarship Program Dermatologic Conditions 2025 Initiative
PRESS RELEASE published on 04/10/2025 at 22:15, 1 year 6 months ago Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program Bausch Health launches 2025 ASPIRE HIGHER Scholarship Program offering $10,000 scholarships to students impacted by dermatologic conditions. Application open until June 11, 2025 Bausch Health Education Scholarships Dermatologic Conditions ASPIRE HIGHER Scholarship Program
Published on 10/15/2026 at 19:25, 22 minutes ago Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption
Published on 10/15/2026 at 16:10, 3 hours 37 minutes ago North Shore Announces Extension to Falcon Property Option Agreement and Resource Stock Digest Engagement
Published on 10/15/2026 at 15:15, 4 hours 32 minutes ago Gold Terra to Host Community Town Hall Meeting in Yellowknife on October 21, 2026
Published on 10/15/2026 at 14:31, 5 hours 16 minutes ago First Breach to Present at the 20th Annual LD Micro Main Event
Published on 10/15/2026 at 14:05, 5 hours 42 minutes ago Innodata to Report Third Quarter 2026 Results
Published on 10/15/2026 at 18:03, 1 hour 44 minutes ago AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:00, 1 hour 47 minutes ago Supervisory Board appoints Dr. Marc-Alexander Mahl to the Fresenius Management Board and extends Sara Hennicken’s contract
Published on 10/15/2026 at 18:00, 1 hour 47 minutes ago EQS-Adhoc: AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:50, 57 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 2 hours 2 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 07:27, 12 hours 20 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
